AI use without an operating model
Like many growing companies, Theiagen’s teams were using AI through individual tools and subscriptions, with no shared approach to data handling, review, or cost.
Since June 2026, Galang AI has worked alongside the Theiagen Genomics team on AI strategy, governed knowledge access, business operations, and the platform behind theiagen.com. Here is what the partnership covers, how it is governed, and what has shipped so far.

Galang AI is a Virginia-based AI consulting and implementation company. It works with Theiagen Genomics, a pathogen genomics and public health bioinformatics company, as its AI technology partner.
The work is practical by design. Galang AI helps Theiagen put AI to work in the business around the science: how knowledge is found, how quotes and statements of work move, how leadership sees priorities, and how marketing and the website get produced. Theiagen’s people stay in charge of every decision, and scientific claims always go through scientific review.
The partnership was announced publicly on July 13, 2026, and continues as an ongoing monthly engagement.
Theiagen already had deep science and mature processes. The opportunity was to make the company’s knowledge and workflows easier to use, without adding risk.
Like many growing companies, Theiagen’s teams were using AI through individual tools and subscriptions, with no shared approach to data handling, review, or cost.
Commercial, project, and delivery knowledge lived across Notion, Google Drive, meetings, contracts, quotes, and the expertise of individual people.
Theiagen wanted to move faster on proposals, operations, and marketing without bypassing the scientific, healthcare, and client-review obligations its work depends on.
Six workstreams make up the partnership. Each one connects to the systems Theiagen already uses rather than replacing them.
The redesigned theiagen.com, a CMS the Theiagen team controls, and a reviewed path from change request to production.
See the detailsStructured, human-reviewed quote and statement-of-work generation with deterministic pricing safeguards.
See the detailsA governed delivery board and executive dashboard that show priorities, decisions, and what needs attention now.
See the detailsA context layer that lets authorized employees ask questions of approved Theiagen information and get source-grounded answers.
See the detailsRole-based training, reusable AI skills, tool selection, and clear rules for review and data handling.
See the detailsCampaign planning, content development, social media support, and proof assets, with human approval before anything is published.
See the detailsWhat has been built, what is in progress, and how each piece is meant to work.
Galang AI redesigned and rebuilt theiagen.com, which launched in September 2026. The site runs on a fast static architecture with a content management system the Theiagen team controls, so everyday updates no longer depend on a vendor or a specialist.
Changes follow a reviewed path. A plain-language change request becomes a tracked code change, gets checked on a staging site, and only then goes to production.
Quotes and statements of work are where commercial risk tends to hide: inconsistent language, pricing errors, and version confusion. Galang AI is building Theiagen a structured path from opportunity to signed work.
AI drafts and people approve. Pricing comes from deterministic rules rather than a language model, and every generated document is reviewed before it reaches a customer. These workflows are running in beta while Theiagen tests and accepts them.
Theiagen’s leaders need one place to see what is on track, what is at risk, and what needs a decision. Galang AI built a restricted delivery board that tracks outcomes through explicit acceptance gates, and is extending it into an executive dashboard.
At the July 2026 delivery-governance review, the board held 32 outcome cards, and 31 were tied to a retained artifact or source record. That measures traceability, not completion: a card only counts as done once Theiagen accepts it.
Much of what makes Theiagen good lives in documents, meeting notes, and people’s experience. Galang AI is building a governed context layer so authorized employees can ask questions of approved company information and get answers that point back to their sources.
Access follows Theiagen’s permissions, answers are grounded in approved material, and the system supports people’s judgment rather than replacing it.
Tools only pay off when people use them well. Galang AI runs role-based training and hands-on working sessions, starting with the people closest to each workflow, and helps Theiagen choose, consolidate, and govern the AI tools it pays for.
Galang AI supports Theiagen’s marketing with planning, content development, social media, campaigns, and proof assets. AI speeds up drafting and repurposing, and Theiagen’s reviewers approve everything before it goes out.
Theiagen’s existing systems remain the source of truth. AI helps connect, draft, and summarize, while Theiagen’s business owners and scientific reviewers keep approval.
Galang AI builds steps 2 and 3. Theiagen owns the data in step 1, the judgment in step 4, and the record in step 5.
AI output is a draft until a qualified person reviews it. Nothing AI-generated is used as the sole basis for a scientific, clinical, legal, or financial decision.
Theiagen’s confidential information is not used to train general-purpose or third-party AI models without Theiagen’s written approval, and it is not put into public AI tools that would train on it.
New workflows run alongside existing ones first. Automation comes second, and a full cutover happens only once the new way has proven itself.
Each capability comes with documentation of its hosting, dependencies, and running costs, plus a knowledge-transfer session, so Theiagen is never locked in.
Galang AI mapped where Theiagen’s operating knowledge lives and started building the business operations model, the SOW generation path, and the new website.
Galang AI and Theiagen Genomics announced their AI enablement and strategy partnership. The governed delivery board reached 32 tracked outcomes by the July review.
The work became an ongoing monthly program covering strategy, enablement, operations automation, CRM adoption, and marketing, with priorities set in weekly sessions.
The redesigned site launched with a Theiagen-controlled CMS, commercial lab pages, CRM-connected contact forms, and structured data for search and AI answers.
Measured results, observed changes, and open questions are kept separate. Several workflows are still in testing or awaiting acceptance, and this page says so.
| Area | Before | Now | Evidence |
|---|---|---|---|
| Delivery visibility | Work and evidence spread across systems and meetings | 32-card governed delivery board; 31 cards tied to a source record | Measured, July 2026 review |
| Website editing | Changes needed vendor and specialist coordination | Plain-language request, tracked change, staged review, then production | Observed |
| Quote-to-cash | Manual, fragmented handoffs | Structured workflows with deterministic pricing and human review | Observed, in beta |
| Business KPIs | No agreed baseline yet | Client testing and acceptance in progress | Not yet measured |
Source: Galang AI’s published Theiagen case study. No revenue, headcount, or scientific-performance outcome is attributed to this work.
“Theiagen is doing the kind of work that changes what is possible for public health. Their team pairs deep scientific expertise with a real willingness to rethink how research, data, and technology come together. We are proud to support that vision and help turn AI’s potential into practical, responsible capability.”

Galang AI (GALANG, LLC) is an AI consulting and implementation company based in Aldie, Virginia. It was founded in 2025 by Ara Galang, CEO and co-founder, and James Galang, president and co-founder.
Galang AI builds AI strategy, custom AI agents, retrieval-augmented knowledge systems, workflow automation, and managed AI operations for organizations that need AI to work inside their real processes. Its approach at Theiagen is the same one it uses everywhere: start with how the organization already works, keep people in control, and measure what changes.
Galang AI is Theiagen Genomics’ AI technology partner. The two companies began working together in June 2026 and announced the partnership publicly on July 13, 2026.
Galang AI supports AI strategy and governance, employee AI enablement, governed knowledge access, quote-to-cash and SOW workflows, leadership visibility, and marketing and web operations, including the design and build of theiagen.com.
Yes. Galang AI redesigned and rebuilt theiagen.com, which launched in September 2026, and continues to support its content and maintenance. The Theiagen team manages site content through its own CMS.
No. AI output is treated as a draft for human review. Scientific, healthcare, legal, and financial decisions stay with qualified Theiagen staff, and scientific claims go through scientific review before anything is published.
No. Theiagen’s confidential information is not used to train general-purpose or third-party AI models without Theiagen’s written approval, and it is not submitted to public AI tools in a way that would let the provider train on it.
Content follows a two-tier review. Routine marketing is approved by Theiagen’s business reviewers. Anything that makes a scientific or healthcare claim also goes through scientific review before it is published.
It is an ongoing monthly engagement. Theiagen and Galang AI agree priorities in weekly working sessions, and work moves through a governed delivery board where Theiagen accepts each outcome before it counts as complete.
Galang AI is an AI consulting and implementation company based in Aldie, Virginia. Founded in 2025 by Ara Galang and James Galang, it builds AI strategy, custom AI agents, retrieval-augmented knowledge systems, workflow automation, and managed AI operations.
Galang AI publishes a case study on its Theiagen work and the original partnership announcement. For questions about Theiagen’s pathogen genomics services, email [email protected].
Talk to Theiagen about your pathogen genomics program, or learn how Galang AI helps organizations put AI to work responsibly.